Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Can Mei Fang Granules is a Traditional Chinese Medicine (TCM) formula presented in granule form. While a precise, comprehensive list of its full ingredients is not publicly detailed, the name '蚕' (Can) strongly suggests the inclusion of '白僵蚕' (Stiff Silkworm, Bombyx Batryticatus) as a primary component. In Traditional Chinese Medicine, '白僵蚕' is traditionally recognized for its properties of calming internal wind, stopping spasms, dispelling wind-dampness, and resolving phlegm. Modern pharmacological research on '白僵蚕' indicates potential anti-convulsant, anti-coagulant, anti-thrombotic, anti-tumor, hypoglycemic, lipid-lowering, antibacterial, sedative, and neuroprotective effects. As a TCM formula, its therapeutic actions are believed to arise from the synergistic effects of its multiple ingredients, addressing various imbalances according to TCM principles. The specific primary indications for the entire 'Can Mei Fang' formula are not widely documented in public English-language sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Can Mei Fang Granules.